Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Microbot Medical Inc

Sanofi

ReNetX Bio

Recerca Clinica SL

Pharmicell Co Ltd

Nordic Life Science Pipeline Inc

Neuralstem Inc

International Stem Cell Services Ltd

Blood ...

Microbot Medical Inc

Sanofi

ReNetX Bio

Recerca Clinica SL

Pharmicell Co Ltd

Nordic Life Science Pipeline Inc

Neuralstem Inc

International Stem Cell Services Ltd

Blood and Tissue Bank

Acorda Therapeutics Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Clinical Trials by G7 Countries: Proportion of Chronic Spinal Cord Injury to Central Nervous System Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Chronic Spinal Cord Injury to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Chronic Spinal Cord Injury Therapeutics Clinical Trials 30

Prominent Drugs 32

Clinical Trial Profile Snapshots 33

Appendix 50

Abbreviations 50

Definitions 50

Research Methodology 51

Secondary Research 51

About GlobalData 52

Contact Us 52

Source 53

List of Tables

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2019* 7

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top ...

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2019* 7

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Chronic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Proportion of Chronic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 14

Chronic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 16

Chronic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 17

Proportion of Chronic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 18

Chronic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20

Chronic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2019* 22

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Chronic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32

List of Figures

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by ...

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Chronic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Proportion of Chronic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 14

Chronic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 16

Chronic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 17

Proportion of Chronic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 18

Chronic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20

Chronic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23

Chronic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26

Chronic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30

Chronic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32

GlobalData Methodology 51

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports